Advances and challenges for gene therapies in Brazil
Brazil, the most populous country in Latin America, has a public Unified Health System (SUS) that constitutionally provides free healthcare to over 200 million people. Advanced Therapy Medicinal Products (ATMP) have revolutionized medicine, offering curative treatments for some diseases. The Lancet Regional Health—Americas article “Clinical trials to gene therapy development and production in Brazil: a review” by Saute et al.1 examines the state of gene therapy in Brazil, highlighting the progress made and challenges that remain.
Authors
- Adriana Bastos Carvalho (ORCID: https://orcid.org/0000-0002-7830-7868)
- Antônio Carlos Campos de Carvalho (ORCID: https://orcid.org/0000-0002-0062-3043)
Institutions
- Universidade Federal do Rio de Janeiro (BR)
- Fundação Oswaldo Cruz (BR)
Publication Details
- Journal
- The Lancet Regional Health - Americas
- Published
- 2025-02-26
- DOI
- https://doi.org/10.1016/j.lana.2025.101035
- Citations
- 4
- Primary Topic
- CAR-T cell therapy research
- Type
- article
- Field-Weighted Citation Impact
- 4.18